return to news
  1. Upstox
    /
  2. News
    /
  3. Market News
    /
  4. IPO
    /
  5. Corona Remedies IPO Listing Date: 5 key things retail investors should know ahead of NSE, BSE debut

Market News

Corona Remedies IPO Listing Date: 5 key things retail investors should know ahead of NSE, BSE debut

Kamal Joshi
By Kamal Joshi

3 min read | Updated on December 12, 2025, 11:46 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Corona Remedies IPO Listing Date: The ₹655.68 crore public offer was only an offer for sale of 0.62 crore shares. As part of the OFS, promoters Dr Kirtikumar Laxmidas Mehta, Minaxi Kirtikumar Mehta, Brinda Ankur Mehta and Dipabahen Niravkumar Mehta are offloading their shares.

Corona Remedies IPO listing date time, nse, bse

Corona Remedies IPO, priced at ₹1,008 to ₹1,062 per share, was subscribed 137.04 times. | Image: Coronaremedies.com

Corona Remedies IPO Listing Date: Shares of pharmaceuticals player Corona Remedies are ready to get listed on the stock exchanges on Monday, December 15. The ₹655.68 crore initial share sale received a strong response from investors during the bidding period. The Corona Remedies IPO allotment status was finalised on Thursday, December 11.
Open FREE Demat Account within minutes!
Join now

With the Corona Remedies share listing just days away, here are the key things retail investors should know.

Corona Remedies IPO: Subscription details

The initial share sale, priced at ₹1,008 to ₹1,062 per share, was subscribed 137.04 times, as investors placed bids for 62,65,41,440 shares as against 45,71,882 shares on offer, as per the data on stock exchanges.

CategoryReservedNo of Shares Bid ForNo of Times
Qualified Institutional Buyers12,88,73235,89,39,448278.52
Non-Institutional Investors9,66,54920,18,97,066208.88
Retail Investors22,55,2816,48,02,03828.73
Total45,71,88262,65,41,440137.04
SpaceX IPO: Rocket maker may go public in 2026 or 2027, potentially raising over $30 billion, says report

Corona Remedies IPO GMP

According to media reports and investorgain.com, unlisted shares of Corona Remedies are trading at ₹1,352, reflecting a grey market premium of 27.31% over the upper price band of ₹1,062.
Disclaimer: Grey Market Premium (GMP) is not regulated or recommended by the stock exchanges or SEBI. Upstox does not endorse or facilitate trading in the grey market. Investors are advised to conduct their own research or consult an expert before making any investment decisions.

Corona Remedies IPO: Objectives

The ₹655.68 crore public offer was only an offer for sale of 0.62 crore shares. As part of the OFS, promoters Dr Kirtikumar Laxmidas Mehta, Minaxi Kirtikumar Mehta, Brinda Ankur Mehta and Dipabahen Niravkumar Mehta are offloading their shares.

Additionally, investors Sage Investment Trust, Sepia Investments and Anchor Partners are also selling their stake.

"Our company expects that listing of the equity shares will enhance our visibility and brand and provide liquidity to its existing shareholders. Listing will also provide a public market for the equity shares in India," the company said in its red herring prospectus.

Corona Remedies IPO: Share credit, refund and listing date

Shares will be credited to the Demat account of successful investors on Friday, December 12. For non-allottees, refunds will be processed on the same day.

The Corona Remedies IPO share listing on the secondary market – the National Stock Exchange (NSE) and the BSE – will take place on Monday, December 15, 2025, at 10 am.

Corona Remedies IPO: Financials

(₹ Crores)FY25FY24FY23
Revenue1,196.411,014.47884.05
Total Assets929.86830.57595.02
Net Profit/(Loss)149.4390.584.92
To learn more about IPOs, their listings, schedules, and upcoming IPOs, visit our page.
To add Upstox News as your preferred source on Google, click here.
SIP
Consistency beats timing.
promotion image

About The Author

Kamal Joshi
Kamal Joshi is a business journalist who covers industries, markets, and IPOs. He is passionate about breaking news and enjoys playing tennis, especially flexing his backhand. He was previously associated with Republic TV and LatestLY.

Next Story